GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **276 - 300** of **4050** in total

« First

‹ Prev

…

8

9

10

11

12

13

14

15

16

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgG	Patient 1	6	moderate	G02557XE	23
IgM	Patient 1	10	moderate	G02557XE	31
IgM	Patient 1	22	moderate	G02557XE	30
IgM	Patient 1	6	moderate	G02557XE	24
IgA	Patient 2	15	mild	G02557XE	235
IgA	Patient 2	24	mild	G02557XE	274
IgG	Patient 2	15	mild	G02557XE	26
IgG	Patient 2	24	mild	G02557XE	26
IgM	Patient 2	15	mild	G02557XE	42
IgM	Patient 2	24	mild	G02557XE	48
IgA	Patient 2	3	mild	G02557XE	240
IgG	Patient 2	3	mild	G02557XE	28
IgM	Patient 2	3	mild	G02557XE	45
IgA	Patient 3	-180	mild	G02557XE	247
IgA	Patient 3	11	mild	G02557XE	420
IgG	Patient 3	-180	mild	G02557XE	46
IgG	Patient 3	11	mild	G02557XE	64
IgM	Patient 3	-180	mild	G02557XE	72
IgA	Patient 3	4	mild	G02557XE	385
IgG	Patient 3	4	mild	G02557XE	53
IgM	Patient 3	11	mild	G02557XE	105
IgM	Patient 3	4	mild	G02557XE	107
IgA	Patient 4	12	mild	G02557XE	371
IgG	Patient 4	12	mild	G02557XE	110
IgM	Patient 4	12	mild	G02557XE	145